Shoreline Biosciences

David Rodgers, Ph.D., Senior Director of Macrophage Cell Therapy

Oct. 12 | 10:30am | Ecolab Life Sciences Ballroom

San Diego, CA


Shoreline Biosciences develops next-generation iPSC-derived natural killer cell (iNK) and macrophage (iMACs) cellular immunotherapy designed to bring safe, effective, and affordable treatments to patients.

By using this website you agree to accept our Privacy Policy and Terms & Conditions